Literature DB >> 908665

Plasmid-mediated pristinamycin resistance. PAC IIA: a new enzyme which modifies pristinamycin IIA.

F L Goffic, M L Capmau, D Bonnet, C Cerceau, C Soussy, A Dublanchet, J Duval.   

Abstract

A wild strain of Staphylococcus aureus which inactivates a wide variety of antibiotics has been found to inactivate pristinamycin IIA, an antistaphylococcal antibiotic. This phenomenon has been demonstrated to be plasmid mediated. The plasmid directs the biosynthesis of an acetyltransferase which is able to O-acetylate the drug. We propose to call the new enzyme PAC (IIA): Pristinamycin acetyltransferase.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 908665     DOI: 10.7164/antibiotics.30.665

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  15 in total

Review 1.  Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.

Authors:  M C Roberts; J Sutcliffe; P Courvalin; L B Jensen; J Rood; H Seppala
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

Review 2.  Antibiotics of the virginiamycin family, inhibitors which contain synergistic components.

Authors:  C Cocito
Journal:  Microbiol Rev       Date:  1979-06

Review 3.  Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria.

Authors:  R Leclercq; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

Review 4.  O-Acetyltransferases for chloramphenicol and other natural products.

Authors:  I A Murray; W V Shaw
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

Review 5.  Antimicrobial resistance of Staphylococcus aureus: genetic basis.

Authors:  B R Lyon; R Skurray
Journal:  Microbiol Rev       Date:  1987-03

6.  Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides.

Authors:  L Wondrack; M Massa; B V Yang; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

7.  Stereospecific reduction of virginiamycin M1 as the virginiamycin resistance pathway in Streptomyces virginiae.

Authors:  C K Lee; M Minami; S Sakuda; T Nihira; Y Yamada
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

8.  Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.

Authors:  J Sutcliffe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

9.  Macrolide-lincosamide-streptogramin resistance patterns in Clostridium perfringens from animals.

Authors:  G N Dutta; L A Devriese
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

10.  Analysis of pristinamycin-resistant Staphylococcus epidermidis isolates responsible for an outbreak in a Parisian hospital.

Authors:  V Loncle; A Casetta; A Buu-Hoi; N el Solh
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.